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AN ANALYTICAL STUDY OF CARCINOMA ESOPHAGUS AND ITS SURGICAL 
MANAGEMENT 
 
INTRODUCTION: 
 Carcinoma esophagus is the 6th most common cancer in the world. Worldwide 
 incidence is 160/100000. Incidence is more in kazakhastan. Squamous cell carcinoma  
accounts for most of the  esophageal cancers. 
 In  USA adenocarcinoma is prevalent. Male to  female ratio is 3:1 in squamous cell  
carcinoma. In adenocarcinoma  it  is 15:1. 
Mostly seen in fifth decade of life.  Rare before the age of 30 years.                     
squamous cell cancers arise from the squamous epithelium of the esophagus. Smoking 
and alcohol increases the risk for foregut cancers. 
Nitrosamines, longterm ingestion of hot liquids, vitamin A deficiency, zinc deficiency,  
achalasia, bulimia,Plummer Winson syndrome also accounts for causative factors. 
Adenocarcinomas are due to increasing incidence of GERD, western diet, increased use  
of acid suppression drugs.  
Due to increased intake of caffine and spicy, fatty foods lead on to lax LES ,inturn lead  
on to metaplastic columnar epithelium called as barret’s esophagus, may lead on to 
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 adenocarcinoma of the lower 1/3 of esophagus,and upto cardioesophagial junction. 
Histologically adenocarcinoma arising from three sites. They are submucosal  
glands,heterotopic islands of columnar epithelium,barret’s esophagus. Patients with  
aerodigestive tract  cancers have increased risk of developing squamous cell carcinoma in  
esophagus. Genetic alterations have also increased risk of developing carcinoma 
 esophagus. 
In recent years the improved standard of investigations and surgical technique and  
perioperative and post operative care substantial reduction in morbidity and mortality has 
 been achieved. 
 But still most of the patients could not be diagnosed earlier because of the late 
 Presention. 
 Study of the carcinoma esophagus is interesting because of its biological 
 behavior. It infilterates locally, involves adjacent lymphnodes, and metastasizes widely 
by hematogenous spread. 
The prognosis and survival rate is poor in esophageal carcinoma. Overall 5 year survival 
 rate is with treated tumour is only 5-12% 
AIM OF THE STUDY 
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The objectives of this prospective clinical study are  
1) To know the incidence of carcinoma with regards to age, sex in our region 
 
2) To study the common histological types of carcinoma esophagus 
 
3) To know the clinical features & possible investigations to aid the diagnosis 
 
4) To know the common site of carcinoma in esophagus 
 
5) To know the operability of the carcinoma esophagus 
 
 
 
 
 
 
 
 
 
HISTORY: 
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One of the earliest descriptions of esophageal cancer was in the second century AD, 
Galen described a fleshy obstructing growth in the esophagus, which was responsible for 
 the inability to swallow and led to emaciation and death. In early Chinese literature, a 
 patient who had esophageal cancer was described as “one suffers in autumn, and does 
 not live to see the coming summer.”Improvement in treatment strategies has resulted in 
 better outcome. However, most patients are still diagnosed at an advanced disease stage,  
with consequent poor prognosis. In 1877, Czerny was the first to successfully resect a 
 cervical esophageal cancer and the patient lived for 15 months. Torek in 1913 
performed the first successful transthoracic resection. A 67-year-old woman had a  
squamous cell cancer of the midesophagus,  through a left thoracotomy, the esophagus 
 was resected. The proximalcervical esophagus was brought out through an incision 
 anterior to the sternocleidomastoid muscleand tunneled subcutaneously along the 
 anterior chest wall, where a cutaneous esophagostomy was fashioned. The patient was 
 fed via a rubber tube connecting the esophagostomy with a gastrostomy. The patient  
lived for 17 years. The first successful resection of a thoracic esophageal cancer with 
 reconstruction using the stomach was performed by Ohsawa, a Japanese surgeon in 
 Kyoto, who reported the technique in 18patients in 1933. In 1946, Lewis described 
 esophageal resection using a two-phase approach via aright thoracotomy and  
laparotomy. Tanner independently also described the procedure in 1947. 
 
Although surgical resection has remained the mainstay treatment for esophageal cancer,  
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Recent years have seen a proliferation of treatment options especially with regards to 
 different combinations of chemotherapeutic agents, radiotherapy and surgery. 
 
 
 
ANATOMY 
EMBRYOLOGY 
 The development of the esophagus is among those remarkable feats, and a few moments 
to appreciate the product of years of precise development will establish a sound basis on 
which normal and abnormal esophageal form and function can be understood. The 
development of the esophagus begins in week 3 of gestational life  , by the 14th week, the 
fetus takes its first swallow. To give life to the esophagus, there are several aspects of 
esophageal development that must be described carefully, initial formation of the gut 
tube, molecular regulation of the gut tube, differentiation of the endoderm (the lining of 
the esophagus), and derivation of the muscular layers from mesoderm. 
 
 
GROSS ANATOMY:  
The esophagus is a two-layered, mucosa-lined muscular tube that travels through the 
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 neck, chest, and abdomen and lies in the posterior mediastinum.  
It starts at the base of the pharynx at C6 and terminates in the abdomen, where it  
joins the cardia of the stomach at T11. Total length of esophagus is around 25 cm.  
The cervical esophagus begins as a midline structure that deviates slightly to the left of  
the trachea At the level of the carina, it deviates to the right to accommodate 
the arch of the aorta. It then winds its way back under the left mainstem  
bronchus and remains slightly deviated to the left as it enters the diaphragm through the  
esophageal hiatus at the level of the 11th thoracic vertebra. 
 In the neck and upper thorax,  the esophagus is secured between 
 the vertebral column posteriorly and the trachea  anteriorly. 
 At the level of the carina, the heart and pericardium lie directly anterior to the 
 thoracic esophagus. 
 Immediately before entering the abdomen, the esophagus is pushed 
 anteriorly by the descending thoracic aorta that accompanies the esophagus through 
 the  diaphragm into the abdomen separated by the median arcuate ligament. 
The journey through the muscular esophagus begins and ends with two pressure zones, 
the upper (UES) and lower esophageal sphincter (LES).  
The high-pressure zone at the inlet of the esophagus is the UES, which anatomically 
 marks the end of a complex configuration of muscles that begins in the larynx and 
 posterior pharynx and ends in the neck.  
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The pharyngeal constrictor muscles are three  consecutive muscles that begin at the base 
of the palate and end at the crest of the  esophagus.  
The superior and middle pharyngeal constrictor muscles, as well as the 
 oblique, transverse, and posterior cricoarytenoid muscles, are immediately proximal to 
 the UES and serve to anchor the pharynx and larynx to structures in the mouth and 
 palate. These muscles also aid in deglutition and speech, but are not responsible for the 
 high pressures noted in the UES. The inferior pharyngeal constrictor muscle is the final  
bridge between the pharyngeal and esophageal musculature ,inserting into the median 
pharyngeal raphe, the inferior pharyngeal constrictor muscle is  composed of two 
consecutive muscle beds—the thyropharyngeus and cricopharyngeus muscles—that 
originate bilaterally from the lateral portions of the thyroid and cricoids cartilages, 
respectively. The transition between the oblique fibers of the thyropharyngeus muscle 
and the horizontal fibers of the cricopharyngeus muscle creates a point of  potential 
weakness, known as Killian’s triangle.                                                               
 The cricopharyngeus muscle is responsible for generating a high-pressure zone  
of muscle fibers is unique and serves to transition into the circular esophageal 
 musculature.  
 
 
This point of transition is flanked by the longitudinal esophageal 
 muscles that extend superiorly to attach to the midportion of the 
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 posterior surface of the cricoids cartilage and form the V-shaped area of Laimer. 
  
ESOPHAGEAL LAYERS: 
 
The esophagus is comprised of two proper layers, the mucosa and muscularis 
propria.  It  is distinguished from the other layers of the alimentary tract by its lack of a 
serosa. The  mucosa is the innermost layer and consists of squamous epithelium for most 
of its  course. The distal 1 to 2 cm of esophageal mucosa transitions to cardiac mucosa or 
 junctional columnar epithelium at a point known as the Z-line .  
 The mucosa contains four layers ,the epithelium, basement membrane, lamina 
 propria, and muscularis mucosae. Deep to the muscularis mucosa lays the submucosa 
 Within it is a plush network of lymphatic and vascular structures, mucous glands and  
meissener’s plexus. 
 
 
The esophagus is composed of two concentric muscle bundles, an inner circular 
and outer  longitudinal layers. 
 Both layers of the upper third of the esophagus are striated, whereas 
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 the layers of the lower two thirds are smooth muscle. The circular muscles are an  
extension of the cricopharyngeus muscle and traverse through the thoracic cavity into the 
 abdomen, where they become the middle circular muscles of the lesser curvature of the 
 stomach. The collar of Helvetius marks the transition of the circular muscles of the 
 esophagus to oblique muscles of the stomach at the incisura (cardiac notch).Between the 
 layers of esophageal muscle is a thin septum comprised of connective tissue, blood 
 vessels, and an interconnected network of ganglia known as Auerbach’s plexus. 
 
 Enshrouding the inner circular layer, the longitudinal muscles of the esophagus 
begin at the cricoid cartilage and extend into the abdomen, where they join the 
longitudinal musculature of the cardia of the stomach.  
 
DIVISIONS OF ESOPHAGUS: 
1.Cervical (lower border of cricoid cartilage to suprasternal notch / thoracic inlet, 5 cm long, 
begins 15 cm from incisors); contains striated muscle. 
 
2.thoracic esophagus 
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 Upper thoracic (suprasternal notch to tracheal bifurcation, 5 cm long, begins 20 cm from 
incisors); has striated and smooth muscle 
 Mid-thoracic (tracheal bifurcation to diaphragmatic hiatus, 5 cm long, begins 24 cm from 
incisors); has striated and smooth muscle 
 Lower thoracic and abdominal (10 cm long, begins 30 cm from incisors); extends past 
diaphragm to its junction with stomach; has smooth muscle only. 
3. abdominal 
FIGURE: 1 
 
ANATOMIC NARROWING: 
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The esophageal silhouette resembles an hourglass. There are three distinct areas of 
 narrowing that contribute to its shape. Measuring 14 mm in diameter, the  
cricopharyngeus muscle is the narrowest point of the gastrointestinal tract and marks the  
superior most portion of the hourglass-shaped esophagus. Located just below the carina,  
where the left mainstem bronchus and aorta about the esophagus, the bronchoaortic 
 constriction at the level of the fourth thoracic vertebra creates the center narrowing and 
 measures 15 to 17 mm. Finally, the diaphragmatic constriction, measuring 16 to 19 mm,  
marks the inferior portion of the hourglass and is located where the esophagus joins the 
 stomach. 
 Between these three distinct areas of anatomic constriction are two areas of 
dilation known as the superior and inferior dilations. Within these areas, the esophagus 
resumes the normal diameter for an adult and measures approximately 2.5 cm. 
 
 
 
GASTROESOPHAGEAL JUNCTION 
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The UES and LES mark the entrance and exit to the esophagus, respectively. 
These  sphincters are defined by a high-pressure zone. The UES corresponds reliably to 
the cricopharyngeus muscle, but the LES is near the gastro esophageal junction. 
 There are four anatomic points to identify the  
gastroesophageal junction (GEJ), two endoscopic and two external. Endoscopically, there 
 are two anatomic considerations that may be used to identify the GEJ. The squamo 
columnar epithelial junction  may mark the GEJ provided that the patient does not  
have a distal esophagus replaced by columnar-lined epithelium, as seen with Barrett’s 
 esophagus.  
The transition from the smooth esophageal lining to the rugal folds of the  
stomach may also identify the GEJ accurately. Externally, the loop  of Willis, where the 
circular muscular fibers of the esophagus join the oblique fibers of  
 the stomach. 
 
 
 
 
 
VASCULATURE: 
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The esophagus has  rich vascular and lymphatic supply. 
The vasculature is divided into  three segments, they are 
  cervical, thoracic, and abdominal. The cervical esophagus receives  its 
 blood supply from the inferior thyroid arteries, which is a branch of  thyrocervical 
 trunk on the left and the subclavian artery on the right . The cricopharyngeus 
 muscle, which marks the inlet of the esophagus, is supplied by the superior thyroid 
 artery. The thoracic esophagus receives its blood supply directly from four to six  
esophageal arteries coming off the aorta, as well as esophageal branches off the right and 
 left bronchial arteries. It is supplemented by descending branches off the inferior thyroid  
arteries, intercostal arteries, and ascending branches of the paired inferior phrenic  
arteries. The abdominal esophagus supplied by the left gastric artery 
 and paired inferior phrenic arteries. 
 
 
 
 All the arteries that supply blood to the esophagus terminate in a fine capillary network 
 before they penetrate the muscular wall of the esophagus. After penetrating and  
supplying the muscular layers, the capillary network continues the length of the 
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 esophagus within the submucosal layer. 
The venous drainage parallels the arterial supply. In all parts of the esophagus, the 
rich  submucosal venous plexus is the first basin for venous drainage of the esophagus. In 
the cervical esophagus, the submucosal venous plexus drains into the inferior thyroid 
veins, which are tributaries of the left subclavian vein and right brachiocephalic vein. The 
 drainage of the thoracic esophagus is more intricate. The submucosal venous plexus of 
 the thoracic esophagus joins with the more superficial esophageal venous plexus and the 
 venae comitantes that envelop the esophagus at this level. This plexus, in turn, drains 
 into the azygos and hemiazygos veins on the right and left sides of the chest, 
 respectively. The intercostal veins also drain into the azygos venous system. 
 The abdominal esophagus drains into the systemic and portal venous systems 
through the left  and right phrenic veins and left gastric (coronary) vein and short gastric 
veins,  respectively. 
 
 
 
 
 
 
 
FIGURE 2: 
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LYMPHATICS: 
The lymphatic drainage of the esophagus  consists of two interconnecting 
 lymphatic plexuses arising from the submucosa and muscularis layers. The submucosal 
 lymphatics penetrate the muscularis propria and drain into the plexus that runs 
 longitudinally in the esophageal wall. They then egress and drain into regional lymph 
 node beds. In the upper two thirds of the esophagus, lymphatic flow is upward, whereas 
 in the distal third, flow tends to be downward. 
 Esophageal lymphatics begin in the neck  with drainage to the paratracheal lymph 
nodes anteriorly and deep lateral cervical and  internal jugular nodes laterally and 
posteriorly. Once inside the chest, the lymphatics  form a matrix of interconnecting 
channels that drain into the mediastinal lymph nodes and thoracic duct. Anteriorly, the 
paratracheal and subcarinal lymph nodes, and the  paraesophageal, retrocardiac, and 
infracardiac nodes, all drain the esophagus. 
 
Other mediastinal stations, such as the para-aortic and inferior pulmonary ligament 
 nodes, can also receive drainage from the thoracic esophagus. Posteriorly, nodes along 
 the esophagus and azygos veins are the primary sites of drainage.  
 
 
 
The  intricate lymphatic network of the esophagus, allows rapid spread of 
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 infection and  tumor into three body cavities. 
 It stands to reason that the rich arterial supply to the  esophagus makes it one of the more 
durable organs in the body with respect to surgical  manipulation, whereas its 
comprehensive venous and lymphatic drainage create an oncologic challenge to 
controlling cellular migration. 
 
 These anatomic complexities lead to surgical challenges when treating esophageal 
cancer and other esophageal diseases. 
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FIGURE 3:  
LYMPHATIC DRAINAGE OF ESOPHAGUS : 
   
 
 
 
INNERVATION 
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 The innervation to the esophagus is sympathetic and parasympathetic . The 
cervical sympathetic trunk arises from the superior ganglion in the neck. It extends next 
to the  esophagus into the thoracic cavity, where it terminates in the cervicothoracic  
ganglion. 
  Along the way, it gives off branches to the cervical esophagus. The thoracic 
sympathetic  trunk continues on from the stellate ganglion, giving off branches to the 
esophageal  plexus, which envelops the thoracic esophagus anteriorly and posteriorly. 
Inferiorly, the  greater and lesser splanchnic nerves innervate the distal thoracic 
esophagus. 
 In the  abdomen, the sympathetic fibers lay posteriorly alongside the left gastric 
artery. The parasympathetic fibers arise from the vagus nerve, which gives rise to the  
superior and recurrent laryngeal nerves. The superior laryngeal nerve branches into 
 the external and internal laryngeal nerves that supply motor innervation to the inferior 
 pharyngeal constrictor muscle and cricothyroid muscle and sensory innervation to the 
 larynx, respectively. The right and left recurrent laryngeal nerves come off 
 the vagus nerve and loop underneath the right subclavian artery and aortic arch, 
respectively. 
  They then travel upward in the tracheoesophageal groove to enter the 
 larynx laterally underneath the inferior pharyngeal constrictor muscle. Along the way, 
 they innervate the cervical esophagus, including the cricopharyngeus muscle. 
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 Unilateral  injury to the superior or recurrent laryngeal nerve results in hoarseness and 
aspiration  from laryngeal and UES dysfunction. In the thorax, the vagus nerve sends 
fibers to the  striated muscle and parasympathetic preganglionic fibers to the smooth 
muscle of the  esophagus. 
 
 A weblike nervous plexus envelops the esophagus throughout its thoracic 
 extent. These sympathetic and parasympathetic fibers penetrate through the muscular 
 wall, forming networks between the muscle layers to become Auerbach’s plexus and 
 within the submucosal layer to become Meissner’s plexus. 
  
 They provide an  intrinsic autonomic nervous system within the esophageal wall that is 
responsible for  peristalsis. The parasympathetic fibers coalesce 2 cm above the 
diaphragm into the left (anterior) and right (posterior) vagus nerves, which descend 
anteriorly onto the fundus  and lesser curvature and posteriorly onto the celiac plexus, 
respectively. 
 
 
 
PHYSIOLOGY 
Chicago architect Louis Sullivan is well known for his progressive philosophy that for 
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 should follow function. The primary function  of the esophagus is to transport material 
from the pharynx to the stomach. Secondarily, the esophagus needs to constrain the 
amount of air that is swallowed and the amount of  material that is refluxed.  The 
esophagus usually measures 30 cm, extending from the pharynx down onto the  cardia of 
the stomach. Under ideal physiologic conditions, the concentric muscular  configuration 
permits effortless unidirectional flow of material from the top to the  bottom of the 
esophagus. The UES, 4 to 5 cm in length, remains in a constant state of  tone (mean, 60 
mm Hg), preventing a steady flow of air into the esophagus. The tone in the LES (mean, 
24 mm Hg) remains elevated just enough to prevent excessive  food refluxing back up 
into the esophagus .                                                                               
  Transport of a food  bolus from the mouth through the esophagus into the stomach 
begins with swallowing  and ends with post relaxation contraction of the LES, requiring 
coordinated peristaltic  contractions. The material in transit can move easily because the 
esophageal  neuromuscular form provides all functions necessary to power the food bolus 
through  three body cavities. 
 
CARCINOMA ESOPHAGUS 
EPIDEMIOLOGY 
Carcinoma esophagus has the greatest variation in geographical distribution. Squamous 
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 cell carcinoma is endemic in the Transkei region of South Africa and in the asian 
  “cancer belt”  extends up to middle asia, shores of Caspian sea to china. Highest  
incidence in the world is in Linxianin henan provine in china. There the incidence is more 
 and it is the most common cause of death, 100/100000 population. 
 In linxian, supplementation of the diet with beta carotene,vitamin E, and selenium has 
been reduce  the incidence Tobacco and alcohol are the major factors for squamous cell 
carcinoma. In western  countries the incidence of adenocarcinoma is increasing. 
Incidence rate varies from  various parts of the world. It is 5/100000 in USA to 26.5 in 
france. Increase in incidence of adenocarcinoma also noted. 
 
 
 
 
 
ETIOLOGY 
DIETARY: 
Pickled vegetables, preserved meat, salted dry fish (rich in nitrosamines). 
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micro nutirient deficiency-vitamin A,B12,C,E,beta carotene. 
Trace elements deficiency-Co,Cu,Mo,Zi. 
ACQUIRED 
Tobacco chewing 
Smoking 
Alcoholism 
Chronic oesophagitis 
Achlasia Cardia 
Barret’s esophagus 
Corrosive strictures 
Plummer Winson syndrome 
Other aero digestive tract malignancy 
 
HEREDITARY 
Tylosis-autosomal dominant disorder charecterised by hyperkeratosis of palms and soles, 
 more prone for squamous cell carcinoms. 
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PATHOLOGY 
SQUAMOUS CELL CARCINOMA 
Squamous cell carcinoma accounts for the most of the upper and middle third of  
esophageal tumours. It arises from the esophageal mucosa and histologically it is  
characterized by invasive sheets of cells that run together  and are polygonal, oval or 
 spindle shaped with a distinct or ragged stromal epithelial interface. 
They are mainly located in thoracic esophagus 60% of these tumours found in mid 
 thoracic esophagus and 30% are in lower 1/3  
 
 
 
Four major pathological presentations  are, 
1) Fungating type 
2) Ulcerative variety 
3) Infilterative variety 
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4) Polypoidal growth          
 
ADENOCARCINOMA 
It usually originates from the barett’s esophagus following long standing 
 gastroesophagial reflex and it is the most common type in U.S. It arises from the  
superficial & deep glands of esophagus mainly in lower third of esophagus, 
 near the OG  junction. 
It may have 3 origins 
1. Submucosal glands of the esophagus 
 
2. Heterotopic islands of columnar epithelium 
 
3. Malignant degeneration of metaplastic columnar epithelium. 
 
 
Other uncommon malignancies of esophagus: 
Both the squamous cell carcinomas and adenocarcinomas,accounts for 98% of all 
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 malignancies of the esophagus. The remaining 2% comprises a variety of unusual tumors 
 that can arise from different layers and structures within the esophagus, including the 
 mucosa, submucosa, muscularis propria, and adventitia Among them, neuroendocrine 
 tumors, carcinosarcomas, melanomas, and sarcomas are the most common. They each 
 have distinct locations and characteristic patterns of spread  
 
Neuroendocrine Tumors 
 
They are small cell tumors that originate from the 
 
1) argyrophilic or argentaffinic cells of the esophageal mucosa  (or) 
 
2)  carcinoid tumors that arise from cells of the amine uptake and decarboxylation 
(APUD) system. 
 
 Small cell tumors are the most common of the unusual malignant tumors found in the 
 esophagus. Both types of tumors are found primarily in the distal esophagus and carry a 
 poor prognosis. 
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Carcinosarcomas 
Carcinosarcomas are rare entities that are composed of carcinomatous and sarcomatous  
elements. The exact cause is not yet proven. 
 
 The number of theories prevail: 
 
1. Collision theory, whereby two separate tumors collide and become one 
 
2. Stem cell theory, whereby both types of cells originate from the same stem cell, 
 with dedifferentiation of the carcinomatous cells into sarcomatous cells 
 
3. Theory that the sarcomatous portion represents reactive hyperplasia, not 
malignancy 
 
These lesions are often polypoid, are found in the lower two thirds of the esophagus, and  
carry a prognosis similar to their individual elements. 
 
 
Malignant Melanomas 
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  Malignant melanomas arise from malignant transformation of melanocytes 
in the mucosa .Which are superficial to the lamina propria.  
They account for 17% of all unusual esophageal tumors. Presented as 
 polypoid, ulcerated, pigmented mass in the lower two thirds of the esophagus. 
 Satellite lesions may also be present. More than 50% of patients present with 
metastatic  disease at the time of diagnosis. They are most commonly found in the distal 
two thirds of the esophagus and usually carries poor prognosis if there is evidence of 
disease outside the  esophagus. 
 
Sarcomas 
Sarcomas are a heterogeneous group of tumors that include leiomyosarcomas and 
 Kaposi’s, sarcoma. They constitute less then 1% of all unusual tumors. 
 Leiomyosarcomas are the most common and arise from the smooth muscle in the 
 muscularis mucosa and muscularis propria. 
  
 
CLINICAL FEATURES 
The symptoms of esophageal cancer vary with the stage of the disease. Early 
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 cancers may be asymptomatic or mimic symptoms of GERD. Heartburn, regurgitation, 
 and indigestion are symptoms of reflux. 
 Most patients with esophageal cancer present with dysphagia and weight loss,  
 that usually  indicate advanced disease. Both are present in almost 80-90% of  
patients.  
Because of the distensibility of the  esophagus, a mass can 
 obstruct two thirds of the lumen before symptoms of dysphagia are noted.  
The symptoms of dysphagia and weight loss may be slowly progressive and well 
 compensated for over a period of months. It is not until the esophageal lumen is 
 narrowed from an average of 24 to 12 mm that dysphagia is noted.  
 
Choking, coughing, and aspiration from a tracheoesophageal fistula, as well as 
 hoarseness and vocal cord paralysis from direct invasion into the recurrent laryngeal 
 nerve, are ominous signs of advanced disease. Systemic metastases to liver, bone, and 
 lung can present with jaundice, excessive pain, and respiratory distress. 
Rarely severe bleeding from erosion in to the aorta and pulmonary vessels may occur. 
 
 
STAGING 
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Staging of the tumour is the critical step in determining the therapeutic option , and which 
 is appropriate .staging done by American Joint Committee on Cancer. It is a TNM based 
 system .The “T”(tumour) indicates the progressive degree of invasion of the tumour into 
 the esophageal wall. “N” stands for the nodal status.”M” is for metastasis. 
 
 Prognosis and outcomes are determined by stage. Five year survival rate for  
esophageal cancers are stage І , 50 to 55%  stage ІІ, 15-30%  stage ІІІ, 6-17%  
 stage ІV, less than 5%. 
Lymph nodal staging may be assessed by endoscopic ultrasound, CT, PET scan, video 
 assisted thoracoscopy and laparoscopy. 
Primary Tumor (T) 
 
T Primary tumor cannot be assessed 
 
T0 No evidence of primary tumor 
 
Tis High-grade dysplasia 
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T1 Tumor invades lamina propria, muscularis 
 
 mucosae, or submucosa 
 
T1a Tumor invades lamina propria or muscularis  
 
mucosae 
 
T1b Tumor invades submucosa 
 
T2 Tumor invades muscularis propria 
 
T3 Tumor invades adventitia 
 
T4 Tumor invades adjacent structures 
T4a Resectable tumor invading pleura, pericardium, 
or diaphgragm 
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T4b Unresectable tumor invading other adjacent 
 
 structures, such as aorta, vertebral body,  
 
Trachea, etc. 
 
Regional Lymph Nodes (N) 
 
NX Regional lymph nodes cannot be assessed 
 
N0 No regional lymph node metastasis 
 
N1 Metastasis in 1-2 regional lymph nodes 
 
N2 Metastasis in 3-6 regional lymph nodes 
 
N3 Metastasis in 7 or more regional lymph nodes 
 
Distant Metastasis (M) 
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M0 No distant metastasis 
 
M1 Distant metastasis. 
STAGING : 
Stage 0                    T0 N0 M0 
   Tis N0 M0 
Stage І  T1 N0 M0 
Stage ІІ ІІA      T2 N0 M0 
   T3 N0 M0 
  ІІB T1 N1 M0 
   T2 N1 M0 
Stage ІІІ  T3 N1 M0 
   T4 Any N M0 
Stage ІV  Any T Any N M1 
CURRENT STAGING CLASSIFICATIONS 
Based upon the survival analysis indicating tumour penetration and lymph node 
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 metastases as the major prognostic factors,WNM (wall penetration, node and distant  
metastases) system for staging was developed by skinner et al. 
 
In the Ellis classification, the W represents the depth of wall penetration (W0, 
muscularis  mucosae; W1, submucosa and muscularis propria; W2, adventitia), N 
represents the  number of positive lymph nodes (N0, none; N1, one to four; N2, >4), and 
M represents  distant disease (M0, none; M1, any). In both systems, the depth of invasion 
 and extent of local and regional lymph node involvement affect prognosis. However, the 
 Ellis classification emphasizes depth of invasion and 
 number of lymph nodes  affects survival. 
 
 
 
 
 
INVESTIGATIONS 
1)x-ray chest: 
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 The evidence of lung secondaries and plural effusion. Mediastinal widening  
can be noted 
 
2)Esophagraphy 
A barium esophagram is recommended for any patient presenting with dysphagia. 
 The esophagram provides an overview of anatomy and function. 
 It can differentiate intraluminal from intramural lesions and discriminate between 
 Luminal  (from a mass protruding into the lumen) and extra luminal 
 (from compression of a structures outside the esophagus) compression. 
 The classic finding of an apple core lesion in patients 
 with esophageal cancer is recognized easily, it is a good first test 
 to perform in patients presenting with dysphagia and a suspicion of carcinoma 
esophagus.  
 
FIGURE 4: BARIUM SWALLOW STUDY 
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Upper gastro intestinal Endoscopy 
  The diagnosis of esophageal cancer is best made from an endoscopic 
biopsy.  
 
 During endoscopy document the following things 
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1. Location of the lesion (with respect to distance from the incisors) 
 
2. Nature of the lesion (e.g., friable, firm, polypoid) 
 
3. Proximal and distal extent of the lesion 
 
4. Relationship of the lesion to the cricopharyngeus muscle, GEJ, and gastric cardia 
 
5. Distensibility of the stomach 
 
 These points is important in the management of esophageal cancer and  guides the 
 surgical therapy. Endoscopy performed by the operating surgeon before  
entering the operating room is must for a definitive resection. 
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FIGURE 5: UGI SCOPY SHOWING CARCINOMA ESOPHAGUS 
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Computed Tomography 
 
CT scans are used for accurate staging. 
 A CT scan of the chest and abdomen is important to assess the length of the tumor, 
 thickness of the esophagus and stomach, regional lymph node status  
 and distant disease to the liver and lungs. 
The regional lymph nodes are cervical, mediastinal, and celiac lymph nodes.  
 It is also helpful for determining T4 lesions which  invades surrounding structures. 
 It can identify a tracheo- esophagial fistula or other anatomic variations. 
 The aortic wall invasion is predicted with an accuracy rate of 80% . 
The overall CT scans accuracy is only 57% for T staging, 74% for N staging, and 
 83% for M staging. 
 
 
 
 
Ultrasound abdomen 
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By doing USG abdomen we can find out the ascitis, lymph nodes, liver metastases. 
 
Endoscopic ultrasound 
EUS is used for staging of esophageal and  EUS will help in  medical and surgical 
 therapy. The endoscopic ultrasound can identify 
1) the depth and length of the tumor 
 2)degree of luminal compromise 
 3)status of regional lymph nodes 
 4)involvement of adjacent structures. 
 5) biopsy samples can be obtained from  the mass  
 The accuracy of EUS for T staging correlates directly with increasing T stage. 
 For T1 lesions, EUS is 84% accurate, and  95% accuracy in estimating T4 lesions. 
 lymph nodes smaller than 1 cm tend to be evaluated less accurately.  
The overall sensitivity (78%) and specificity (60%) of EUS for evaluating lymph nodes. 
 
Magnetic Resonance Imaging 
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 Measurement of esophageal wall thickness in the absence of luminal air are other 
 contrast agents is difficult. Visualization of the middle third esophagus is complicated by 
 artifacts resulting cardiac and respiratory motion. It can detect T4 disease and 
 secondaries. At the same time, it tends to over stage the lymph node and T disease. 
 
Bronchography  
 Bronchoscopy is performed in any patient presenting with a cough or evidence of 
a cervical esophageal cancer. 
 It is helpful to rule out a tracheoesophageal fistula or growth of tumors into the trachea. 
Blunting of the carina seen in metastatic involvement of the carina by the primary mass. 
Cytological sampling from the subcarinal node can be done. 
 
 
 
 
Positron Emission Tomography 
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An 18F-fluorodeoxyglucose (FDG)–positron emission tomography (PET) scan evaluates 
 the primary mass, regional lymph nodes, and distant disease. 
 Its sensitivity and specificity more than CT scan, but they remain low for definitive 
 staging. The sensitivity and specificity of PET for evaluating metastatic disease are as 
 high as 88% and 93%, respectively. For evaluation of lymph node disease, PET has a 
 sensitivity (72%), specificity (86%), and accuracy (76%) equivalent to CT. As with 
 CT, the ability of PET to evaluate local and regional lymph node disease is dependent on 
 the location of the tumor, size of the lymph node, and technique of the scanner. PET 
 appears to be an important piece of the diagnostic workup but is 
 not reliable enough as a single diagnostic modality. 
 
 
 
 
Other investigations 
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Mediastinoscopy is used for upper and middle thoracic esophageal lesions  
to assess the mediastinal lymph nodes. 
Percutaneous needle biopsy of suspected extra nodal metastases can be done. 
The efficacy of the video assisted thoracoscopy is described by Kraska and collegues  as  
sensitivity is 80% and the specificity is 100%. 
Laparoscopy can be done in patients with suspected sub diaphraghmatic involvement in 
 CT abdomen. 
 
 
 
 
 
 
 
 
TREATMENT 
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Operative treatment 
Middle thoracic and lower thoracic carcinomas 
Lewis-tanner operation 
Transhiatal esophagectomy 
Three phase esophagectomy 
Trans thoracic Esophagectomy(left/right  thoracotomy approach) 
Thoracoscopic esophagectomy 
Cardia 
Transhiatal esophagectomy 
Esophagogastrostomy(left thoraco- abdominal approach) 
Esophagogastrectomy(abdominal right chest approach) 
Abdominal gastrectomy 
 
 
Bypass 
Kirschner gastric bypass 
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Colonic bypass 
Jejuna bypass 
In our hospital we are doing trans hiatal esophagectomy and thoracoscopic 
esophagectomy usually. 
TRANSHIATAL ESOPHAGECTOMY 
It is performed through an upper midline abdominal and cervical incision with out 
thoracotomy. Thoracic esophagus is resected through an widened diaphraghmatic hiatus 
and the neck.the stomach is mobilized by dividing left gastric and left gastro epiploic 
vessels. Right gastric and right gastro epiploic vessels preserved. 
The entire thoracic esophagus from the level of clavicle to the cardia is resected. During 
this surgery we should care fully moniter intra arterial blood pressure to avoid prolonged 
hypotension resulting from cardiac displacement. The surgical stapler is used to fasion  a 
gastric tube from the greater curvature of the stomach, while preserving the entire length.  
The stomach is mobilized through the posterior mediastinum in the original esophageal 
bed and is anastamosed to the cervical esophagus. 
 For distal third esophageal tumours  ,localized to the cardia, the high lesser 
curvature of the stomach is resected 4 to 6 cm beyond the gross tumour, while  preserving 
the point on the high greater curvature that reaches cephaladfor the cervical esophago 
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gastric anastamosis. Critics of THE object to the limited exposure afforded by the hiatus 
to the intra thoracic esophagus. The limited exposure increases the risk of bleeding. 
Contraindications to this surgery is evidence of tumour invasion of tumour 
invasion of the pericardium, aorta,trachea bronchial tree. 
 
 
THORACOSCOPIC ESOPHAGECTOMY 
In our hospital we are doing Video assisted thoracoscopy / laparoscopy also  in 
performing esophagectomy now.  
In this procedure, thoracic esophagus is mobilized by right thoracoscopy,in a 
prone position. Followed by laparoscopic mobilization of cardiac end , and the stomach is 
mobilsed stomach tube is formed, anastomosed with the cervical esophagus. 
 
 
 
 
FIGURE 7: SPECIMEN OF MIDDLE 1/3 CARCINOMA 
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RECONSTRUCTION AFTER ESOPHAGECTOMY: 
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FIGURE 8: 
 
STOMACH TUBE - RECONSTRUCTION 
 
 
 
 
After a portion of the esophagus is removed a conduit must be established for 
alimentary tract continuity. The stomach, colon, and jejunum have all been successfully 
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used as esophageal substitutes, but the stomach appears to be the conduit of choice 
because of it is easy mobilization and ample blood supply. 
The mortality is very high in cases of triple anastomoses (coloesophagostomy, 
colojejunostomy, and colocolostomy) 
RADIATION THERAPY 
Patients who undergo external-beam radiation therapy, used alone in the treatment 
of esophageal carcinoma, have only 5-10% 5 year survival, so this therapy is not curative. 
The relief of dysphagia is shortlived, and recurrence is seen usually within 6 
months. 
The range is from 5000cGy in 20 treatments over 4 weeks to 6600cGy in33 
fractions over 7 weeks. 
Complications of radiotherapy are pnueumonitis ,pericarditis ,myocarditis , 
stricture, fistula formation. 
 
 
 
 
CHEMOTHERAPY 
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Chemotherapy is not a effective treatment in carcinoma esophagus as a single 
modality. Chemotherapy will treat systemic disease and help reduce the overall tumor 
burden. 5 fluro uracil and cisplatin are the mostly used drugs. However, it usually needs 
to be given in combination with radiation therapy so that control of the local tumor is 
obtained . 
 
 Treatment for Palliation 
 Palliative measures include chemotherapy, radiation therapy, photodynamic 
therapy, laser therapy, esophageal stenting, feeding gastrostomy or jejunostomy, and 
esophagectomy. These measures are aimed at reducing tumor burden or restoring 
nutritional access and should be considered in any patient who has no chance for cure or 
would not withstand the rigors of treatment for cure. Most studies dealing with 
neoadjuvant chemotherapy are based on combinations that contains cisplatin.response 
rates vary between 25-50% Meluch and colleagues treated 49 patients with localized 
esophageal cancer with paclitaxel, carboplatin, low dose 5FU with concurrent 
chemotherapy. 
Dilatation  is to palliate dysphagia and to allow endoscopic evaluation with a       
2-3%  risk of esophageal wall rupture or bleeding. Unfortunately, relief is measured only 
in weeks. Patints with high grade malignant strictures more likely present with advanced 
disease. 
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The purpose of Stenting , is to bridge the obstruction in the esophagus to allow 
luminal patency primarily to prevent poolingof saliva and secondarily for nutrition. 
PHOTODYNAMIC THERAPY 
For photodynamic therapy, a photosensitizer  such as dihematoporphyrin ether, is 
given intravenously and after 2 to 3 days is retained in the tumour in a much higher 
concentration than in healthy tissue. Then a low power laser system that produces red 
light is delivered to the tumour by a flexible endoscope. 
Two to three days after this therapy, esophagoscopy is repeated and the necrotic 
tissue is removed, often monthly. Complications include development of fistulas and 
aspiration. Edema of the face ,hand, sensitivity to light are the complications.  
 
 
  
 
 
MATERIALS AND METHODS 
This is a prospective study of 88 patients of carcinoma esophagus who were admitted in 
thanjavur medical college hospital from September 2013-june 2015.  Total number of 
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carcinoma esophagus admitted in our hospital during this study  period were 112. Out of 
which 24 patients in whom the carcinoma  arising from cervical esophagus were 
excluded from the study.   
METHODS 
The methods include, obtaining the important information from the patients through 
history thorough clinical examination and doing the investigations, what ever is necessary 
to aid the diagnosis and respectability. 
All the informations were entered in a proforma, specially designed for this study. 
METHODOLOGY 
The following factors were taken into consideration while evaluating the patients. 
-Age and sex incidence 
-Geographical factors 
-Socio economic status 
-Personal habits 
-Symptoms and duration 
-Predisposing factors 
In all these patients, nourishment was noted. 
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 Abdomen was examined for any mass, hepatomegaly, ascitis. Rectal examination was 
done, to find out bloomer’ shelf. Respiratory system was examined to find out plural 
effusion and signs of aspiration pneumonia. 
They were all subjected to basic investigations which included 
1)urine albumin, sugar 
2)blood hemoglobin 
3)blood sugar 
4)blood urea 
5)serum creatinine 
6)xray chest 
Specific investigations such as  
1) Upper GI Endoscopy and biopsy 
2) Barium swallow 
3) Ultrasound abdomen 
4) CT thorax and abdomen 
The upper GI Endoscopy was done in all patients and the biopsy was taken from the 
growth.the presence, location, type of growth and its distance from incisors were 
studied. 
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All patients who had a positive endoscopy and biopsy were submitted for Ultrasono 
gram of abdomen to rule out any metastases 
CT Thorax was done to study the location of tumour, esophsgial wall thickness, 
extent of tumour. The presence of mediastinal lymphadenopathy and direct invasion 
of adjacent vital structures like Trachea, Aorta, Heart, etc., are noted and hence the 
respectability was noted. 
CT abdomen revealed the presence of heparic, adrenal secondaries. 
Broncoscopic examination was done in necessary cases to rule out trachea bronchial 
involvement. 
After obtaining necessary informations from these investigations and clinical 
examinations planned for curative are palliative treatment, mainly Transhiatal 
esophagectomy, Thoracoscopic esophagectomy, palliative feeding jejunostomy 
follow up  radiotherapy referral to radio oncology department 
 
 
EXCLUSION CRITERIA 
1. patients with carcinoma involving upper third esophagus(cervical) 
2.patients with previously diagnosed and treated for carcinoma esophagus. 
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Totally 88 patients were diagnosed to have carcinoma esophagus. Out of 88 patients 
we found out 41 patients can undergo curative surgery, feeding jejunostomy in 
remaining 47patients done. 
With available facilities in our hospital we adapted transhiatal esophagectomy in 37 
patients and thoracoscopic esophagectomy in 3 patients , total gastrectomy with 
esophagectomy done in 1 patient. 
Post operative complications were identified promptly and managed accordingly.most 
of our patients who underwent surgery, were reviewed in our OPD department.uring 
follow up we examined for complications like anastamotic leak,and evidence of 
recurrence, distant metastases.Patients who underwent  feeding jejunostomy were 
referred for radio therapy. 
 
 
 
OBSERVATIONS AND RESULTS 
The incidence of carcinoma esophagus, by this study in our institution is  5.2%  
(112/2120)  
Total number of cancer patients in our hospital during this study period were 2120. 
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Total number of carcinoma esophagus were 112. 
TABLE 1 : AGE INCIDENCE 
AGE GROUP(YEARS) NO.OF CASES PERCENTAGE 
≤ 30 4 5% 
31 -40 11 13% 
41 – 50 19 22% 
51-60 22 25% 
61-70 24 26% 
71 -80 7 8% 
>80 1 1% 
TOTAL 88 100% 
 
 
 
FIGURE 8: 
AGE DISTRIBUTION OF CARCINOMA: 
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TABLE 2 : SEX INCIDENCE 
Age group males percentage Females percentage 
0
5
10
15
20
25
30
≤30 31 -40 41-50 51-60 61-70 71-80 >80
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 (years) 
≤30 2 2% 2 2% 
31-40 4 5% 6 7% 
41-50 11 13% 8 9% 
51-60 17 19% 6 7% 
61-70 16 18% 8 9% 
71-80 6 7% 1 1% 
>80 0 0 1 1% 
total 56 64% 32 36% 
 
FIGURE 9: 
 
The relation of carcinoma of esophagus and personal habits has been well established in 
various studies 
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TABLE 3:  
HABITS NO.OF PATIENTS PERCENTAGE 
TOBACCO 8 9% 
BETAL NUT 17 19% 
SMOKING 27 30% 
ALCOHOL 24 27% 
2 or more habits 19 21% 
 
According to our study smoking(30%), Alcohol (27%)  users are prone to get carcinoma 
esophagus .  
Next is the betal nut chewer contributes about 19% .  
Out  of these 21% has 2 or more habits. 
  
 
 
 
TABLE 4 :CLINICAL FEATURES 
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COMPLAINTS Number of cases percentage 
Dysphagia 86 98% 
Weight loss 55 62% 
Anorexia 20 23% 
Vomiting 15 17% 
Abdominal pain 18 20% 
Chest pain 3 3% 
Cough 4 5% 
Hoarseness  0 0% 
Dyspnoea 3 3% 
Malena 2 2% 
 
Among the presenting complaints , the commonest and in many a times the only 
complaint was dysphagia(98%). The second most common was the weight loss(62%) 
next is the anorexia and abdominal pain, vomiting. All other symptoms was very less, 
and those symptoms were due to metastases or complications. No one patient was having 
hoarseness of voice. 
 
TABLE 5: 
 
 
61 
 
 
Distribution of tumour according to site of tumour 
location Number of cases percentage 
Upper1/3 24 21% 
Middle 1/3 52 48% 
Lower 1/3 21 18% 
OGJ 15 13% 
 
FIGURE 10: 
 
 
 
 
Upper 1/3
middle 1/3
lower1/3
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There was a considerable variation in the statistics as for as the location of the tumour is 
considered. The commonest site of the carcinoma of esophagus was the lower 3rd on our 
institution, about 52 patients were having middle third carcinoma  (46%). Lower 3rd 
along with OGJ contributes 31% (36 ) cases. 
Various studies have documented a major shift in the histological pattern of the cancer 
esophagus, with a double fold rise from a traditional squamous cell carcinoma to 
adenocarcinoma over the last few decades. But, observations made in our study results do 
not correlate well with the changing trend as far as the histological pattern is concerned. 
The commonest histological pattern is still squamous cell carcinoma in our institution. 
TABLE 6 : OGD SCOPY FINDING 
TYPE OF GROWTH NUMBER OF CASES PERCENTAGE 
Fungating 3 3% 
Ulcerative 45 51% 
Infiltrative 38 43% 
polypoid 2 2% 
 
Most of patients (51%) were found to have ulcerative growth. Infiltrating type growth 
(43%)were the second most common type of growth. Rarely about  3 % were polypoid 
growth. 
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TABLE 7 : HISTOLOGICAL VARIETIES  
TYPE NUMBER OF CASES PERCENTAGE 
SQUAMOUS 70 80% 
ADENO 18 20% 
TOTAL 88 100% 
 
FIGURE 11: 
 
 
 
 
 
HISTOLOGICAL VARIETY
Squamous
ADENO CA
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TABLE 8 : CURATIVE AND PALLIATIVE SURGERY 
SURGERY NO.OF CASES PERCENTAGE 
Trans hiatal 
esophagectomy 
37 42% 
Thoracoscopic 
Esophagectomy 
3 3% 
Feeding Jejunostomy 47 54% 
Total gastrectomy with 
Esophagectomy 
1 1% 
 
Patients were selected for curative surgery according to their general condition, scopy 
findings, extent of disease, histological grade of lesion, with out any metastases and 
complications. Patients selected for curative surgery were planned for either transhiatal 
esophagectomy or thoracoscopic esophagectomy. 
Patients in whom there is no curative resection possibility , underwent feeding 
jejunostomy and follow up Radiotherapy.   
 
Out of those 88 patients,  47 patients were underwent feeding jejunostomy followed by 
radio therapy. These 47 patients had one of these following exclusion criteria. 
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TABLE 9 : PATIENTS UNDERWENT PALLIATIVE FJ 
FACTORS NUMBER OF CASES PERCENTAGE 
>80 years 2 2% 
Co morbid illnesses 4 5% 
Poor general condition 8 9% 
Extensive growth 24 27% 
metastases 6 7% 
Not willing for major 
surgery 
3 3% 
TOTAL 47 53% 
 
About 2 patients were in extreme age. 4 patients had co morbid illness like recent attack 
of Myocardial infarction (2) , complete heart block (1) , and severe COPD(1). 8 patients 
had very poor general condition made them unfit for surgery. 24 patients had extensive 
growth that explains biological nature of the disease. 6 patients had metastases to 
adjacent structures , such as bronchi, loss of fat plane and abutment between the aorta and 
esophagus  and distant metastases like liver secondaries and ascitis, diagnosed by pre 
operative CT chest and USG abdomen and CT abdomen. 3 patients were refused for 
major surgery after explaining the post operative morbidity and mortality 
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All these patients undergone palliative feeding jejunostomy and referred to Radio 
Therapy unit for further management. 
Patients (41) who had curative surery like trans-hiatal esophagecomy , thoracoscopic 
esophagectomy  had following post operative complications. 
TABLE 10:  
COMPLICATIONS NUMBER OF CASES PERCENTAGE 
Wound infection 3 7% 
Anastomotic leak 6 14% 
Stricture 1 2% 
Wound dehiscence 4 9% 
Pneumonitis 2 5% 
Hemothorax 0 0% 
Death 1 2% 
Total 17 39% 
 
3 patients had wound infections and 4 patients had wound dehiscence were managed 
conservatively and settled in follow up of those patients. 6 patients had anastamotic leak 
in post operative ward itself, those were managed as in patients, conservatively. 
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Leak stopped and discharged  after that. 2 patients developed pnemonitis treated 
medically. 1 died in post operative period itself. 
According to above observations immediate postoperative mortality was 2%.  
Follow up periods of (41) patients were variable. 
TABLE 11 : 
PERIOD NUMBER PERCENTAGE 
<1 MONTH 2 4 
1 – 3 MONTHS 5 12 
4-6 MONTHS 7 17 
7-12 MONTHS 15 36 
1 -1 ½  YEARS 4 9 
1 ½ - 2 YEARS 3 7 
LOST FOR FOLLOW UP 5 12 
 
During follow up visits patients wer subjected to investigations to find out any recurrence 
and any evidence of metastases. Those patients were referred for radiotherapy department 
in our hospital for further management. 
Since the study period was 1 year 10 months survival rate could not be calculated with 
these above data. 
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STASTICAL ANALYSIS 
 SCC ADENO.CA Marginal row 
total 
SMOKERS 16(21.48)(1.4) 11(5.52)(5.43) 27 
NON-SMOKERS 54(48.52)(0.62) 7(12.48)(2.4) 61 
TOTAL 70 18 88 
 
Chisquare stastic is 9.8517 
“p” value is 0.001697 
This result is significant at p<0.05. 
 SCC ADENO TOTAL 
ALCOHOL 16 8 24 
NON-ALCOHOL 
USERS 
54 10 64 
 70 18 88 
 
 
69 
 
 
 
Chisquare stastics is 3.364 
“p” value 0.0495,  significant at <0.05 
 
SITE OF 
CARCINOMA 
CURATIVE 
SURGERY 
FJ TOTAL 
Middle 1/3 28 24 52 
Lower 1/3 13 23 36 
total 41 47 88 
 
The chi-square stastic is 2.6889. The “p” value is 0.10 >0.05 
It is not significant. 
 
 SCC ADENO CA TOTAL 
CURATIVE  
SURGERY 
34 7 41 
FJ 36 11 47 
 70 18 88 
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Chi-square stastic is 0.5394 
“p” value is 0.46 > 0.05 not significant. 
DISCUSSION 
EPIDEMIOLOGY, SEX AND AGE INCIDENCE 
The epidemiological characteristics of esophageal carcinoma are unusual, since the 
incidence in different geographic areas is extremely variable, with the greatest differences 
recorded for all tumours. The incidence of esophageal carcinoma varies from 8.1% 
recorded at Chennai registry to 4.6% in Delhi. The incidence as per the surveillance made 
by the National Cancer Registry Project (NRCP) quotes an incidence of 8.6% at 
Bangalore and 6.8% AT Mumbai. The incidence of carcinoma esophagus in our 
institution is 5.2%. 
As per the study, the rise in esophageal cancer commences in the thirties and peaks in the 
6th decade. Studies conducted both in India and abroad, show peak incidence in the 7th 
and 8th decades. 
ETIOLOGY AND RISK FACTORS 
All the patients in our study, who presented with esophageal carcinoma were of the lower 
socioeconomic group. Day and Munoz, 1982 and Scottenfeld 1984 , and several other 
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series have shown an association between esophageal cancers and low socioeconomic 
status. 
 
 
 
Low levels of retinol, riboflavin, ascorbic acid and alpha tocoferol are prevalent in 
population of Linxian, china where esophageal cancer is epidemic. In Japan, poor food 
variety has been identified as a risk factor and combination of fruits and vegetable, sand 
fresh meat appear to be risk reducing factors. 
De Carli et al 1989 has stated that low intake of fruits, particularly citrus fruits has much 
of vitamin C associated with increased risk deficiency of Zinc, Molybdenum, also cited 
as possible etiological factors. 
Francheschi et al 1990 discovered that deficiencies are believed to make one more 
susceptible to the carcinogenic effects of exogenous factors. 
From the data given in our study there is strong association between the use of tobacco in 
both of its forms of usage (chewing, smoking) 
The most important risk factors for cancer esophagus in developed countries are cigarette 
smoking (IARC 1986) alcohol consumption (IARC 1988). The association between 
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cigarette smoking and alcohol consumption and esophageal cancer are difficult to 
separate, largely because of the correlation in the two exposure and their mutual 
association with the risk of cancer esophagus. 
 
 
 
The risk of esophageal cancer has shown to be increased among non tobacco smokers 
who consumes alcohol and non-drinkers of alcohol who smokes tobacco. (La Vecchia 
and Negri 1989) 
The role of alcohol consumption was not clearly demonstrated in the French Department 
of Ille-et-Villaine where the risk rose steadily with the amount of alcohol consumed 
(Tuyns et al 1977) 
The risks associated with tobacco use appears to increase with the number of cigerettes 
smoked per day, duration of smoking and tar content (Tuyns et al 1979; Rossi et al1982; 
Yu et al  1988) 
The synergistic effect for the combined habit of alcohl drinking and tobacco smoking or 
chewing has also been reported. 
MORPHOLOGICAL TYPE AND LOCATION 
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 The prominent histological type noted in our hospital is squamous cell carcinoma 
 ( 80% ) 
In Europe and America adenocarcinoma is more prevalent. 
Stiger et al 1987 , stated that primary adenocarcinoma represent 3- 8 %  of the 
esophageal cancer. Observations made in our study also show a rise in the incidence of 
adenocarcinoma.  (20%) 
Esophageal cancer is usually located in the middle third in about 50% and in upper and 
lower third esophagus contributes only less.( Guili and Gignoux 1980). 
In our study , we found same result as that of Guili and Gignoux 1980 The middle third  
 carcinoma  is contributing about 48%  . 
 Lower third and upto OGJ were about 31% .Carcinoma in Upper third is 21%  
SURGICAL THERAPY 
In the past the esophagial surgery was burdened by high operative morbidity and 
mortality rates (Lauis et al 1983). There has been a remarkable reduction in these rates in 
the last 10 years. 
The preoperative care of a patient who has to undergo esophagectomy should include a 
prophylaxis for any postoperative complications, especially respiratory problems.. 
smoking should be stopped at least 10 days before surgery. And in the presence of 
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pulmonary problems, physiotherapy is advisable together with operative broncho 
dilatation treatment. If the patient with malnutrition hypercaloric parentral nutrition or 
tube feeding at 2500 to 3500 calories per day advisable for a period of 7 – 10 
days.(Moghissi et al 1977) . 
The selection of patients for transhiatal esophagectomy is very important in computing to 
the outcome. Most of the time it depends upon the general condition of the patient and 
the tumour stage. 
The contraindications for esophagectomy can be relative to the patient or to the tumour. 
At present an elderly patient (Perecchia et al 1988) ,length of the tumour and 
concomitance of Child-A risk liver cirrhosis (Fekete et al 1987) are not considered as 
absolute contraindications for surgery. 
SURGICAL APPROACH 
 Transhiatal esophagectomy without thoracotomy (Orringer et al 1993) has been 
performed by an increasing number of authors in recent years. It is performed by 
isolating the mediastinal esophagus through a cervicotomy and laparotomy  (Orringer et 
al 984, 1987.)  We at TMCH , have adopted this technique in the selected patients, for so 
many years.  
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 In the recent time we adopted Thoracoscopic esophagectomy and the operative 
morbidity and mortality is less with this technique. All 3 cases who undergone 
thoracoscopic esophagectomy had less post operative morbidity and mortality.  
Akiyama et al 1978 stated that stomach is the viscus of choice to replace the esophagus 
resectaed for cancer. It is isolated tubulized before transposition.according to this 
statement stomach tubulization allows removal of the lypmhnodes  located the gastric 
vessels, a possible metastasis station, improves the gastric vascularisation and avoids 
mediastinal encumbrance which is possible when the whole stomach is transposed. 
Interpositioning of colonic segment and the transposition of a Roux en Y loop of jejunum 
was done on one case of lower esophageal cancer . 
In our institution, Esophago- gastric anastomosis done by hand sewn technique. 
 
Wong et al 1987 identified that the main post operative complication is the anstomotic 
leakage. The anastomotic leakage rate in our cases is well within our acceptable range. 
It was about 14%. 
RESULTS OF SURGICAL RESECTION  
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Contrasting data regarding the respectability rates and the long term survival rates are 
reported in literature, that is because varying criterias for the selection of patients for 
different types of treatment , biological behavior of the disease. 
 Observations in our study , the mortality rate of about 2.0% 
 
 
 
 
 
TABLE 12 :POST OPERATIVE MORTALITY 
STUDIES PERCENTAGE 
Katariya et al 6.7% 
Moon et al 7.3% 
Michigan university 7.2% 
Goldminc et al 6.4% 
 Bolton et al 5.9% 
Schakelfordt et al 5.7% 
Orringer et al 4.0% 
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Our study 2.0% 
 
 
 
 
 
 
 
FIGURE 12: 
 
Anastomotic leak observed in our study is about 14% . 
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 All were managed conservatively 
 
 
 
 
 
 
TABLE 13: 
STUDIES ANASTOMOTIC LEAK 
Katariya et al 15% 
Goldminc et al 14% 
Michigan university 12.0% 
Schekelfordt et al 13.5% 
Orringer et al 7.9% 
Our study 14% 
 
 FIGURE 13:  
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1 year survival rate according to our study is 25%. 
Since the study period is very less , we are unable to calculate the 
 5 year survival rate.  
CONCLUSION 
Carcinoma esophagus is one among the cancers that hav increased male: female 
ratio. 
More commonly occuring in a low socioeconomic groups. 
The predominant histology is squamous cell variety. 
There is significant rise of adenocarcinoma. 
A strong association coexists  between carcinoma esophagus with smoking and 
alcoholism 
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Transhiatal esophagectomy  and thoracoscopic esophagectomy scores significant 
role in surgical management of lower 1/3 and middle 1/3 carcinomas. 
Around 50% of the patients when diagnosed is in inoperable stage. 
Inoperability is due to biological nature of the disease, in which feeding 
jejunostomy and followup RT is the treatment option. 
Significant 1 year survival rate can be achieved by with transhiatal as well as 
thoracoscopic esophagectomy.  
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CONSENT FORM 
 
I 
here by give consent to participate in the study conducted by postgraduate in Department 
of General Surgery, Thanjavur Medical College, Thanjavur Medical College& Hospital, 
Thanjavur.,and to use my personal clinical data and result of investigation for the purpose 
of analysis and to study the nature of disease. I also give consent for further 
investigations. 
 
Place : 
Date : 
                                                                                              Signature of the participant 
    PROFORMA 
 
NAME                        AGE     SEX 
OCCUPATION   IP.NO   UNIT/WARD 
ADDRESS 
COMPLAINTS: 
 
HISTORY OF PRESENT ILLNESS 
DYSPHAGIA     DURATION 
ODYNOPHAGIA     HOARSENESS 
CHEST PAIN     COUGH 
ANOREXIA      DYSPNOEA 
WEIGHT LOSS     HEMOPTYSIS 
REGURGITATION     HEMATEMESIS 
MALENA      OTHERS 
PAST HISTORY 
IRRDIATION     DIVERTICULA 
CORROSIVE STRICTURE   TYLOSIS 
BARRETS      OTHERS 
PV SYDROME 
PERSONAL HISTORY 
DIET       SMOKING 
ALCOHOL      TOBACCO 
BETAL NUT     OTHERS 
FAMILY HISTORY     
MARITAL STATUS 
PHYSICAL EXAMINATION 
PR    BP    RR 
BUILT   NUTRITION   ANEMIA 
JAUNDICE   LYMPHADENOPATHY 
LOCAL EXAMINATION 
MOUTH AND PHARYNX 
NECK 
CHEST 
ABDOMEN 
SPINE AND CRANIUM 
INVESTIGATIONS 
URINE     HEMOGLOBIN 
RBS      UREA 
CREATININE    ELECTROLYTES 
ECG      CHST XRAY 
ENT OPINION 
BARIUM SWALLOW 
ENDOSCOPY 
BIOPSY 
USG ABDOMEN 
CT THORAX & ABDOMEN 
FNAC  OF LYMPH NODE STATUS 
 
TREATMENT 
TRANSHIATAL ESOPHAGECTOMY 
THORACOSCOPIC ESOPHAGECTOMY 
FEEDING JEJUNOSTOMY  
RADIOTHERAPY 
POST OPERATIVE COMPLICATIONS 
FOLLOW UP 
 
  
   
                          
 
 
 
 
 
S.NO NAME AGE SEX IP NO COMPLAINTS HABITS SITE BIOPSY METS TREATMENT FOLLOW 
UP 
1 RAJAPPA 65 M 37372 D,  LW, LA B, S M S - THE 2M 
2 KASINATHAN 56 M 38747 D, MA, S OGJ A - THE - 
3 RAMASAMY 59 M 40728 D,LW T,B OGJ A - THE 15days 
4 KENNADY 47 M 33799 AP,V S,A OGJ A ASCITIS FJ  
5 GOVINDHAMMA 70 F 36608 D,V B OGJ A - THE 6M 
6 JEGANATHAN 60 M 11333 D,LW,LA S,A L S  FJ  
7 AROCKIYAMARY 62 F 10782 D,LW T M S  THE 1Y 
8 AKILAMBAL 60 F 1655 D,LW - M S  FJ  
9 LAKSHMI 37 F 2684 D,LW B M S  THE 3M 
10 CHITHRA 40 F 2167 D,LW - M S  FJ  
11 MATHEW 58 M 65826 D,LW,LA,AP A,SF OGJ A  FJ  
12 UTHIRAPATHY 53 M 63472 D,LW S M S  FJ  
13 MARIYAMMAL 90 F 63484 D,LW,LA B M S  FJ  
14 SELVAM 49 M 62275 D,LW A M S  THE - 
15 KALYAPERUMAL 60 M 62752 D,V,LW S L S  FJ  
16 KEERIPILLAI 72 M 61428 D,V A L A  FJ  
17 SELLAM 70 F 60291 D,V - L S  FJ  
18 VENUGOPAL 62 M 59067 D,LW S M S  FJ  
19 CHANDRABABU 58 M 57846 AP,V A OGJ A  FJ  
20 RAJAMANICKAM 65 M 57688 D,LW B M S  THE 6M 
21 AROCKIYASAMY 50 M 57241 D,LW,LA S,A L S  FJ  
22 PITCH KANNU 65 M 54162 D,LW,LA,CP T,B M S  FJ  
23 KALYANI 29 F 32845 D,AP - L S  THE 9M 
24 KALA 45 F 31881 D B M S  THE 8M 
25 SUYAMPRAKASAM 60 M 28295 D,AP A,S OGJ S  THE 3M 
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S 
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SIT
E 
BIOPS
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T 
FOLLOWU
P 
26 RADHAKRISHNAN 70 M 24431 D,AP,LW,V A,S OGJ A  TEG 10M 
27 BHARATHIMOHA
N 
40 M 14532 D,AP,V S M S  TLE 7M 
28 RADHAKRISHNAN 67 M 16202 D,LW,LA A,S M S  FJ  
29 AMUTHAN 50 M 11252 D,LW A,S M S  FJ  
30 RAJESWARI 45 F 13021 D B M S  THE 6M 
31 SEETHA 41 F 6977 D,LW,LA - M S  FJ  
32 MAHALAKSHMI 35 F 8825 D,LW B M S  TLE 6M 
33 KARUPPAIYA 65 M 61428 D,LW,LA A M S  FJ  
34 UTHIRAPATHY 53 M 63472 D,MA A,S M S  FJ  
35 VAIRAKKANU 65 M 2642 D,V A,S L S LI 2° FJ  
36 GOVINDHAMMAL 70 F 26193 D,AP T OGJ A  FJ  
37 KRISHNAVENI 55 F 24742 D,AP,V,LW B OGJ A  FJ  
38 GURUMOORTHY 50 M 24719 D,C,CP S M S LU 
2°,B
R 
FJ  
39 NAGOORAN 55 M 33774 D,AP,F A,S M S  FJ  
40 BAVAJ 72 M 35944 D - M S  FJ  
41 GOVINDHAMMAL 70 F 36608 D,AP,LW,LA T L S  THE 3M 
42 MANIMEGALAI 70 F 38305 D,CP, T M S BR FJ  
43 SARATHKUMAR 42 M 36585 D,AP,LW,AL A,S M S LI 2° FJ  
44 YASODHAI 45 F 146998
7 
D,LW B L S  THE 10M 
45 PAKKIRISAMY 80 M 1661 D,LW - L S  THE 2M 
46 NAGALAKSHMI 45 F 148420
6 
D T M S  FJ  
47 JAYALAKSHMI 45 F 148421
1 
D,LW T,B M S  THE 1Y2M 
48 RAVI 40 F 4041 D,LW,LA - L S  THE - 
49 CHITHRA 32 F 38253 D,LW - M S  FJ  
50 RAMALINGAM 63 M 37248 D,LW - OGJ A  THE 11M 
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51 RAJAKANNU 58 M 35466 D,AP,V - OGJ A  THE 11M 
52 JAYAKUMAR 41 M 23584 D,LW - L S  THE - 
53 SADHASIVAM 53 M 22436 D,LW,LA A M S  THE 10M 
54 SURESHKANNA
N 
30 F 53264 D,LW,LA S L S BR FJ  
55 MURUGESAN 60 M 51633 D S M S  THE 1Y3M 
56 MAHALINGAM 67 M 52032 D,V A L A  THE 4M 
57 PITCHI 65 M 49582 D - M S  THE 9M 
58 RAJESH 30 M 48936 D,AP,V,LW,LA A,S L,OGJ S No fat 
plane 
FJ  
59 CHANDRAN 57 M 48427 D - M S  THE 10M 
60 THIGARAJAN 66 M 47276 D,LW A M S  THE 11M 
61 ARUDAI 65 M 39519 D,LW - L S  FJ  
62 BABU 45 M 40459 D S M S  THE 21days 
63 RANJITH 30 M 40759 D S,A M S  THE 8M 
64 LAKSHMI 52 F 44468 D,LW - M S  TLE 1Y 
65 JAYARANI 60 F 46097 D,LW,LA,V - L S  FJ  
66 MARIYAMMAL 45 F 47531 D - M S  THE 9M 
67 GOPAL 45 M 20243 AP,AD A,S OGJ A ASCITIS FJ  
68 NALLATHAMBI 55 M 19650 D A L S  THE 9M 
69 KRISHNAVENI 55 F 21348 D,LW - L S  THE 5M 
70 BELOJI 72 M 22769 D,LW,LA - M S  FJ  
71 BASKER 40 M 25163 D,AP - M S  FJ  
72 SANTHAKUMAR 42 M 36585 D,LW S M S  THE - 
73 SHANTHI 33 F 18766 D,LW - M S  FJ  
74 AMSAVALLI 45 F 10334 D - M S  THE 1Y10M 
75 ANJALAI 70 F 10153 D,LW,LA B M S  FJ  
76 RAMAKRISHNA
N 
74 M 10863 D,AP,LA,LW B L A  FJ  
 
 
 
 
S.NO NAME AGE SEX IP NO COMPLAINTS HABIT SITE BIOPSY CT TREATMENT  
77 RAMAIYAN 75 M 12654 D T M S  FJ  
78 CHELLAPPA 40 M 14741 D,LW - OGJ A  FJ  
79 THAMBIRAJ 60 M 17268 D,AP A OGJ A  FJ  
80 CHITHRAVEL 65 M 18383 D,LW - M S  THE 1Y8M 
81 KRISHNAMOORTHY 60 M 45338 D,LA,V - OGJ A  FJ  
82 SELVARAJ 70 M 74125 D,LW,LA - M S  FJ  
83 KEERTHIVASAN 45 M 59704 D S M S  THE 5M 
84 KARUPAIYA 70 M 65450 D,LW B M S  FJ  
85 NEELAVATHY 60 F 6091 D,LW - L S  FJ  
86 GOWRAMMAL 65 F 65098 D,LW B M S  THE 11M 
87 GOVINDHARAJ 75 M 54832 D,LW - M S  FJ  
88 MANIKANDAN 40 M 53409 D,LW A,S M S  THE 1Y7M 
            
            
            
            
            
            
            
            
            
            
            
            
 
